Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection

被引:16
作者
Minami, Takeshi [1 ]
Miyata, Eriko [1 ]
Sakamoto, Yamato [2 ]
Yamazaki, Hideo [1 ]
Ichida, Seiji [2 ]
机构
[1] Kinki Univ, Dept Life Sci, Sch Sci & Engn, Osaka 5778502, Japan
[2] Kinki Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Osaka 5778502, Japan
关键词
Thimerosal; Ethyl mercury; Metallothionein; Cerebellum; Cerebrum; Capillary zone electrophoresis; NEURODEVELOPMENTAL DISORDERS; MERCURY CONCENTRATIONS; METHYLMERCURY; BRAIN; RAT; EXPRESSION; ASTROCYTES; VACCINES; AUTISM; LOCALIZATION;
D O I
10.1007/s10565-009-9124-z
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Thimerosal, an ethyl mercury compound, is used worldwide as a vaccine preservative. We previously observed that the mercury concentration in mouse brains did not increase with the clinical dose of thimerosal injection, but the concentration increased in the brain after the injection of thimerosal with lipopolysaccharide, even if a low dose of thimerosal was administered. Thimerosal may penetrate the brain, but is undetectable when a clinical dose of thimerosal is injected; therefore, the induction of metallothionein (MT) messenger RNA (mRNA) and protein was observed in the cerebellum and cerebrum of mice after thimerosal injection, as MT is an inducible protein. MT-1 mRNA was expressed at 6 and 9 h in both the cerebrum and cerebellum, but MT-1 mRNA expression in the cerebellum was three times higher than that in the cerebrum after the injection of 12 A mu g/kg thimerosal. MT-2 mRNA was not expressed until 24 h in both organs. MT-3 mRNA was expressed in the cerebellum from 6 to 15 h after the injection, but not in the cerebrum until 24 h. MT-1 and MT-3 mRNAs were expressed in the cerebellum in a dose-dependent manner. Furthermore, MT-1 protein was detected from 6 to 72 h in the cerebellum after 12 A mu g/kg of thimerosal was injected and peaked at 10 h. MT-2 was detected in the cerebellum only at 10 h. In the cerebrum, little MT-1 protein was detected at 10 and 24 h, and there were no peaks of MT-2 protein in the cerebrum. In conclusion, MT-1 and MT-3 mRNAs but not MT-2 mRNA are easily expressed in the cerebellum rather than in the cerebrum by the injection of low-dose thimerosal. It is thought that the cerebellum is a sensitive organ against thimerosal. As a result of the present findings, in combination with the brain pathology observed in patients diagnosed with autism, the present study helps to support the possible biological plausibility for how low-dose exposure to mercury from thimerosal-containing vaccines may be associated with autism.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 65 条
[1]
Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family [J].
Ambjorn, Malene ;
Asmussen, Johanne W. ;
Lindstam, Mats ;
Gotfiyd, Kamil ;
Jacobsen, Christian ;
Kiselyov, Vladislav V. ;
Moestrup, Soren K. ;
Penkowa, Milena ;
Bock, Elisabeth ;
Berezin, Vladimir .
JOURNAL OF NEUROCHEMISTRY, 2008, 104 (01) :21-37
[2]
Methylmercury-induced inhibition of regulatory volume decrease in astrocytes: characterization of osmoregulator efflux and its reversal by amiloride [J].
Aschner, M ;
Vitarella, D ;
Allen, JW ;
Conklin, DR ;
Cowan, KS .
BRAIN RESEARCH, 1998, 811 (1-2) :133-142
[4]
Austin D., 2008, INT J RISK SAF MED, V20, P135, DOI DOI 10.3233/JRS-2008-0436
[5]
Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts [J].
Baskin, DS ;
Ngo, H ;
Didenko, VV .
TOXICOLOGICAL SCIENCES, 2003, 74 (02) :361-368
[6]
Autism: a novel form of mercury poisoning [J].
Bernard, S ;
Enayati, A ;
Redwood, L ;
Roger, H ;
Binstock, T .
MEDICAL HYPOTHESES, 2001, 56 (04) :462-471
[7]
Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal [J].
Burbacher, TM ;
Shen, DD ;
Liberato, N ;
Grant, KS ;
Cernichiari, E ;
Clarkson, T .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2005, 113 (08) :1015-1021
[8]
Role of metallothionein-III following central nervous system damage [J].
Carrasco, J ;
Penkowa, M ;
Giralt, M ;
Camats, J ;
Molinero, A ;
Campbell, IL ;
Palmiter, RD ;
Hidalgo, J .
NEUROBIOLOGY OF DISEASE, 2003, 13 (01) :22-36
[9]
New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration [J].
Chung, R. S. ;
Hidalgo, J. ;
West, A. K. .
JOURNAL OF NEUROCHEMISTRY, 2008, 104 (01) :14-20
[10]
The three modern faces of mercury [J].
Clarkson, TW .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 :11-23